“Neuregulin-4 (Nrg-4) as a Metabolic Regulator: A Comprehensive Review of Its Association with Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus” (2025) Vascular and Endovascular Review, 8(19s), pp. 177–181. doi:10.64149/J.Ver.8.19s.177-181.